BOSTON, Mass. (
) -- A calendar of important, potentially stock-moving biotech events for November:
Oct. 29 - Nov. 2:
S&P 500 and Nasdaq Set Intraday Record Highs on Recovery Optimism
Stocks rise as jobless claims fall and durable goods orders climb at the fastest pace since the beginning of the year.
The American Association for the Study of Liver Disease annual meeting. Hepatitis C drug research from
American Society for Human Genetics annual meeting.
reports third-quarter financial results.
FDA drug approval decision for
Ofirmev for fever and pain indications.
American College of Rheumatology annual meeting.
Chemotherapy Foundation meeting. (Cancer drug research)
Human Genome Sciences
( HGSI): Release expected of FDA's briefing documents on the lupus drug Benlysta in advance of the Nov. 16 advisory panel meeting.
American Heart Association annual meeting.
FDA advisory panel meeting for Human Genome Sciences' lupus drug Benlysta.
: Release expected of FDA's briefing documents on the MELAFind skin cancer detection device in advance of the Nov. 18 advisory panel meeting.
EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics.
Medicaid/Medicare reimbursement review meeting for Dendreon's Provenge.
FDA advisory panel meeting for MELA Sciences' MELAFind.
FDA approval decision date for
Prolia to treat bone complications due to cancer therapy.
--Written by Adam Feuerstein in Boston.
>To contact the writer of this article, click here:
>To follow the writer on Twitter, go to
>To submit a news tip, send an email to:
Adam Feuerstein writes regularly for TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback;
to send him an email.